Cosmeceuticals Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Cosmeceuticals. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Cosmeceuticals Indian Medical PG Question 1: Which of the following are treatment options for acne vulgaris?
- A. Isotretinoin
- B. All of the options (Correct Answer)
- C. Topical erythromycin
- D. Oral Minocycline
Cosmeceuticals Explanation: ***All of the options***
- All listed options (Isotretinoin, Topical erythromycin, and Oral Minocycline) are well-established and commonly used **treatment options for acne vulgaris**, depending on the severity and type of acne.
- The choice of treatment often follows a stepped approach, starting with topical agents for mild to moderate acne and progressing to oral medications like antibiotics or isotretinoin for more severe or resistant cases.
*Isotretinoin*
- **Isotretinoin** is a powerful oral retinoid primarily used for **severe, recalcitrant nodular acne** that has not responded to other treatments.
- It works by reducing sebum production, follicular hyperkeratinization, inflammation, and the growth of *P. acnes*.
*Topical erythromycin*
- **Topical erythromycin** is an **antibiotic** used to treat mild to moderate inflammatory acne by reducing the growth of *Cutibacterium acnes* (formerly *Propionibacterium acnes*) and decreasing inflammation.
- It is often combined with other topical agents like benzoyl peroxide to minimize the development of **antibiotic resistance**.
*Oral Minocycline*
- **Oral minocycline** is a **tetracycline antibiotic** used for moderate to severe inflammatory acne.
- It reduces bacterial populations on the skin and exhibits **anti-inflammatory properties**, making it effective for widespread or deeper lesions.
Cosmeceuticals Indian Medical PG Question 2: Most common side effect of retinoids is
- A. Headache
- B. Diarrhoea
- C. Photosensitivity
- D. Mucocutaneous dryness (Correct Answer)
Cosmeceuticals Explanation: ***Mucocutaneous dryness***
- This is the **most common side effect** of retinoids, particularly oral isotretinoin, occurring in nearly all patients
- Manifests as **cheilitis** (dry, cracked lips), **xerosis** (dry skin), **dry nasal mucosa**, and **conjunctival dryness**
- Direct result of decreased sebaceous gland activity and altered epithelial differentiation
- Managed with **emollients and lip balm**
*Headache*
- Can occur with retinoid use, but less common than mucocutaneous effects
- **Severe headaches** with visual changes may indicate **pseudotumor cerebri** (benign intracranial hypertension), a rare but serious complication requiring immediate discontinuation
*Diarrhoea*
- **Gastrointestinal side effects** are uncommon with systemic retinoids
- Not a characteristic adverse effect of this drug class
*Photosensitivity*
- While retinoids can increase susceptibility to **sunburn**, this is not the most common side effect
- Patients should be advised to use **sunscreen** and avoid excessive sun exposure
- Less universal than mucocutaneous dryness
Cosmeceuticals Indian Medical PG Question 3: Benzoyl peroxide acts in acne vulgaris by:
- A. Decreasing bacterial count (Correct Answer)
- B. Reduces sebum production
- C. Acts as a keratolytic agent
- D. Increases epithelial turnover
Cosmeceuticals Explanation: ***Decreasing bacterial count***
- **Benzoyl peroxide** is a highly effective topical treatment for acne primarily due to its potent **antimicrobial activity** against *Cutibacterium acnes*, the bacterium implicated in acne pathogenesis.
- It works by releasing **free radicals** that disrupt bacterial cell membranes and metabolism, thereby reducing the bacterial load in follicles.
*Reduces sebum production*
- While sebaceous gland activity is critical in acne, benzoyl peroxide does **not directly reduce sebum production**; retinoids like isotretinoin are known for this effect.
- Its primary action is focused on combating bacteria and mildly promoting desquamation rather than affecting **lipid synthesis**.
*Acts as a keratolytic agent*
- Benzoyl peroxide does possess some **keratolytic activity**, aiding in the shedding of dead skin cells and preventing pore blockage.
- However, its keratolytic action is **less pronounced** compared to agents like salicylic acid or tretinoin, and it is not its primary mechanism of action.
*Increases epithelial turnover*
- While benzoyl peroxide does promote a mild increase in **epithelial cell turnover**, helping to clear clogged pores, it is not its main mechanism of action or defining characteristic.
- **Topical retinoids** (e.g., tretinoin, adapalene) are far more effective and primarily used to normalize follicular keratinization and increase cell turnover.
Cosmeceuticals Indian Medical PG Question 4: A 35 years old female presented with acne. She was treated for her acne but after the treatment, she developed pigmentation. Which drug is responsible for hyperpigmentation?
- A. Minocycline (Correct Answer)
- B. Doxycycline
- C. Tetracycline
- D. Erythromycin
Cosmeceuticals Explanation: ***Minocycline***
- **Minocycline** is known to cause different types of hyperpigmentation, including blue-grey discoloration of the skin, scars, mucosa, eyes, and teeth, especially with long-term use.
- This pigmentation can be due to the accumulation of **iron oxide** and **minocycline degradation products** in tissues.
*Doxycycline (a tetracycline antibiotic)*
- While doxycycline is a tetracycline, it is **less commonly associated with significant hyperpigmentation** compared to minocycline.
- It can cause photosensitivity, which might lead to hyperpigmentation in sun-exposed areas, but direct drug-induced blue-grey discoloration is rare.
*Tetracycline (a tetracycline antibiotic)*
- **Tetracycline** can cause tooth discoloration, especially in children, and photosensitivity, but direct drug-induced skin hyperpigmentation as described is **less common** than with minocycline.
- Other side effects like gastrointestinal upset are more prominent.
*Erythromycin (a macrolide antibiotic)*
- **Erythromycin** is a macrolide antibiotic and is **not typically associated with significant skin hyperpigmentation** as a side effect.
- Common side effects include gastrointestinal disturbances like nausea, vomiting, and diarrhea.
Cosmeceuticals Indian Medical PG Question 5: A young boy with oily skin presents with acne as shown. What is the appropriate treatment?
- A. Oral isotretinoin
- B. Oral steroid
- C. Topical retinoic acid (Correct Answer)
- D. Benzoyl peroxide
Cosmeceuticals Explanation: ***Topical retinoic acid***
- The image shows **comedonal acne** with numerous small bumps, which typically responds well to topical retinoids like retinoic acid.
- **Topical retinoids** work by normalizing follicular keratinization and reducing comedone formation, making them the **first-line treatment** for comedonal and mild to moderate inflammatory acne.
- Retinoids are superior to other agents for comedonal acne due to their comedolytic properties.
*Oral isotretinoin*
- **Oral isotretinoin** is reserved for **severe cystic or nodular acne**, or acne that is unresponsive to other treatments, which does not appear to be the case here.
- It has significant side effects and requires close monitoring, making it inappropriate for the initial treatment of mild to moderate acne.
*Oral steroid*
- **Oral steroids** are not a primary treatment for acne and are usually reserved for severe, **fulminant acne** (like acne conglobata) or to manage acute exacerbations of inflammatory acne due to their numerous side effects.
- Their primary role is potent **anti-inflammatory action**, but they do not address the underlying pathogenesis of acne.
*Benzoyl peroxide*
- **Benzoyl peroxide** is effective against **inflammatory acne** due to its antibacterial and keratolytic properties.
- While it can be used for comedonal acne and is often combined with retinoids for enhanced efficacy, **topical retinoids are preferred as monotherapy** for predominantly comedonal acne as shown in this image.
- Benzoyl peroxide is particularly useful when there are inflammatory lesions (papules, pustules) present.
Cosmeceuticals Indian Medical PG Question 6: Which of the following is not true about hydroquinone?
- A. Response is incomplete and pigmentation may recur
- B. It inhibits tyrosinase
- C. It requires prescription strength concentrations above 2%
- D. It should not be used for melasma or chloasma of pregnancy (Correct Answer)
Cosmeceuticals Explanation: ***It should not be used for melasma or chloasma of pregnancy***
- This statement is **NOT TRUE** - hydroquinone is actually a **first-line treatment for melasma** including chloasma (melasma of pregnancy)
- Hydroquinone 2-4% is one of the **most effective topical agents** for treating melasma and is widely recommended in dermatological guidelines
- While hydroquinone use during **active pregnancy** is approached with caution (FDA Category C), it is definitely indicated for treating melasma/chloasma **after pregnancy** and for general melasma in non-pregnant patients
- The condition (melasma/chloasma) is appropriately treated with hydroquinone; only the **timing during pregnancy** requires consideration
*Response is incomplete and pigmentation may recur*
- This is a **TRUE statement** about hydroquinone therapy
- Treatment response is often **incomplete** with partial lightening of hyperpigmentation
- **Recurrence is common** after discontinuation, especially with continued sun exposure or hormonal triggers
- Maintenance therapy is often needed to sustain results
*It inhibits tyrosinase*
- This is a **TRUE statement** - hydroquinone's primary mechanism of action
- Acts as a **competitive inhibitor of tyrosinase**, the rate-limiting enzyme in melanin synthesis
- This inhibition reduces melanin production in melanocytes, leading to depigmentation
*It requires prescription strength concentrations above 2%*
- This is a **TRUE statement** in most countries including India and the USA
- Hydroquinone concentrations **≤2%** are available over-the-counter (OTC)
- Concentrations **>2% (typically 3-4%)** require a prescription
- Higher concentrations provide greater efficacy but also increased risk of side effects like ochronosis
Cosmeceuticals Indian Medical PG Question 7: A cosmetic dermatologist plans to introduce microneedling radiofrequency for acne scars. Which parameter combination would provide optimal collagen remodeling with minimal risk of thermal injury in Fitzpatrick type IV skin?
- A. Needle depth 3.5 mm, temperature 70°C, pulse duration 1000 ms
- B. Needle depth 4 mm, temperature 75°C, pulse duration 500 ms
- C. Needle depth 1.5-2 mm, temperature 60-65°C, pulse duration 100-200 ms (Correct Answer)
- D. Needle depth 0.5 mm, temperature 55°C, pulse duration 50 ms
Cosmeceuticals Explanation: ***Needle depth 1.5-2 mm, temperature 60-65°C, pulse duration 100-200 ms***
- Optimal **collagen remodeling** occurs when the tissue is heated to **60-65°C**, which triggers the denaturation of proteins and the subsequent production of new collagen and elastin.
- A depth of **1.5-2 mm** specifically targets the **papillary and mid-reticular dermis**, while the shorter pulse duration minimizes **Post-Inflammatory Hyperpigmentation (PIH)** in **Fitzpatrick type IV** skin.
*Needle depth 3.5 mm, temperature 70°C, pulse duration 1000 ms*
- Temperatures reaching **70°C** and very high pulse durations significantly increase the risk of **thermal necrosis** and bulk heating injuries.
- A depth of **3.5 mm** is often too deep for standard facial acne scarring and may damage underlying **subcutaneous structures** or cause permanent scarring.
*Needle depth 4 mm, temperature 75°C, pulse duration 500 ms*
- High temperatures of **75°C** cause excessive tissue coagulation, which can lead to localized **skin burns** and prolonged downtime.
- Excessive needle depth combined with high energy delivery poses a severe risk for **atrophic scarring** and pigmentary changes in darker skin types.
*Needle depth 0.5 mm, temperature 55°C, pulse duration 50 ms*
- A depth of **0.5 mm** is generally insufficient to reach the collagen-rich dermis required for significant improvement of **depressed acne scars**.
- A temperature of **55°C** is below the threshold for effective **collagen denaturation**, resulting in suboptimal clinical outcomes for scar revision.
Cosmeceuticals Indian Medical PG Question 8: A 50-year-old man with Fitzpatrick skin type V desires treatment for melasma. He was previously treated with triple combination cream with partial response. What would be the most evidence-based next step considering safety and efficacy?
- A. Fractional CO2 laser resurfacing
- B. Q-switched Nd:YAG laser 1064 nm with low fluence (Correct Answer)
- C. Intense pulsed light therapy
- D. TCA 35% chemical peel
Cosmeceuticals Explanation: ***Q-switched Nd:YAG laser 1064 nm with low fluence***
- This approach, often called **laser toning**, uses a long wavelength that spares the epidermis, making it the safest laser option for **Fitzpatrick skin type V** to avoid **post-inflammatory hyperpigmentation (PIH)**.
- It is a clinically sound next step for **recalcitrant melasma** that has only partially responded to first-line therapies like **triple combination cream**.
*Fractional CO2 laser resurfacing*
- This is an **ablative** treatment that causes significant thermal damage, which carries an unacceptably high risk of **PIH** and scarring in darker skin types.
- While effective for skin remodeling, it is generally contraindicated for treating melasma in **type V skin** due to the likelihood of worsening the pigmentation.
*Intense pulsed light therapy*
- **IPL** uses a broad spectrum of light which is poorly targeted for melasma in dark-skinned individuals and is frequently associated with **rebound hyperpigmentation**.
- The melanin in the surrounding **darker skin (Type V)** competes for the energy, leading to a high risk of **thermal burns** and uneven results.
*TCA 35% chemical peel*
- A 35% concentration of **Trichloroacetic acid (TCA)** is considered a **medium-depth peel**, which is generally too aggressive for patients with Fitzpatrick skin type V.
- Medium-depth peels in dark skin types are likely to cause **persistent dyschromia** or permanent **hypopigmentation**, whereas superficial peels (like glycolic or salicylic acid) are safer.
Cosmeceuticals Indian Medical PG Question 9: A patient treated with Q-switched Nd:YAG laser for nevus of Ota develops paradoxical darkening after 4 weeks. What is the most likely explanation for this phenomenon?
- A. Delayed clearance in deeper dermal melanocytes
- B. Increased melanogenesis due to suboptimal fluence (Correct Answer)
- C. Post-inflammatory hyperpigmentation due to epidermal injury
- D. Conversion to melanoma
Cosmeceuticals Explanation: ***Increased melanogenesis due to suboptimal fluence***
- Paradoxical darkening in **nevus of Ota** during **Q-switched Nd:YAG** therapy often results from **suboptimal fluence**, which triggers reactive **melanogenesis** instead of destroying the target cells.
- This occurs when the energy delivered is sufficient to stimulate **dermal melanocytes** but remains below the threshold required for **selective photothermolysis** and cell destruction.
*Delayed clearance in deeper dermal melanocytes*
- Delayed clearance typically results in a slow resolution of the lesion rather than an actual **increase in pigmentation** or darkening.
- The darkening suggests an active production of **melanin** rather than a passive failure of the lymphatic system to clear debris.
*Post-inflammatory hyperpigmentation due to epidermal injury*
- **Post-inflammatory hyperpigmentation (PIH)** usually presents as a more generalized or superficial brownish tan following **epidermal damage**.
- While common in darker skin types, the term "paradoxical darkening" in the context of dermal lesions specifically refers to the reactive stimulation of **dermal melanocytes**.
*Conversion to melanoma*
- There is no clinical or histopathological evidence that **Q-switched lasers** induce **malignant transformation** or conversion of a benign nevus to **melanoma**.
- While **nevus of Ota** has a small baseline risk of ocular or CNS melanoma, laser-induced darkening is a transient physiological response, not a neoplastic change.
Cosmeceuticals Indian Medical PG Question 10: A 42-year-old woman develops sudden onset vision loss in one eye 2 hours after hyaluronic acid filler injection in the glabella. Fundoscopy shows retinal whitening. What is the underlying pathophysiology?
- A. Compression of supraorbital nerve
- B. Retrograde embolization via angular artery to ophthalmic artery (Correct Answer)
- C. Direct traumatic optic nerve injury
- D. Allergic reaction causing optic neuritis
Cosmeceuticals Explanation: ***Retrograde embolization via angular artery to ophthalmic artery***
- Glabellar filler injection can inadvertently enter the **angular artery**, where high injection pressure forces the filler **retrograde** into the **ophthalmic artery**.
- Once pressure is released, the filler travels antegrade into the **central retinal artery**, causing occlusion and classic **retinal whitening** due to ischemia.
*Compression of supraorbital nerve*
- This would lead to **sensory changes** or pain in the forehead region rather than sudden, painless vision loss.
- Nerve compression does not explain the **fundoscopic finding** of retinal whitening or vascular compromise.
*Direct traumatic optic nerve injury*
- The **optic nerve** is located deep within the orbit and is not typically reachable by standard aesthetic needles used in the glabella.
- Traumatic injury would likely present with an **afferent pupillary defect** without the characteristic **ischemic retinal whitening** associated with artery occlusion.
*Allergic reaction causing optic neuritis*
- **Optic neuritis** presents with painful eye movements and inflammatory changes, rather than the hyper-acute vision loss seen in arterial embolization.
- A localized allergic reaction to **hyaluronic acid** would cause significant swelling and redness at the injection site rather than sudden **retinal ischemia**.
More Cosmeceuticals Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
